✓ Machine Certified10/10?

Does a seed-stage medtech company need a fractional CRO in 2027?

📖 1,762 words6/28/2026

Quick Answer

Yes, if your medtech startup has achieved product-market validation and is ready to build a repeatable sales motion. A fractional CRO typically costs between $5,000 and $18,000 per month depending on scope (2-8 days per week), with an additional 0.5-2% equity grant for seed-stage companies. For a seed-stage medtech firm with limited cash and complex regulatory sales cycles, a fractional CRO is often the most capital-efficient way to access seasoned go-to-market leadership.

Direct Answer

The short answer is: probably yes, but only if you have clear evidence of product-market fit and a handful of paying customers who aren't your co-founder's former colleagues. Medtech is a beast of its own — long sales cycles, regulatory hurdles, and multi-stakeholder buying groups that include clinicians, hospital administrators, and procurement teams. A fractional CRO brings the specific playbook for navigating these dynamics without the $200,000+ base salary and full benefits of a full-time hire. The real question isn't whether you *need* revenue leadership; it's whether you can afford to *not* have it while burning through seed capital on trial-and-error sales motions.

How to decide if a fractional CRO is right for your seed-stage medtech company

Step 1: Validate real product-market fit

At least 3-5 non-referenceable customers paying for a solution that solves a specific clinical or operational pain point.

Step 2: Assess your cash runway

Fractional CROs cost $5k-$18k/month; ensure you have at least 12-18 months of runway after this commitment.

Step 3: Map your sales cycle complexity

If your deal involves FDA clearance, hospital system procurement, or multi-stakeholder approvals, a fractional CRO with medtech experience is critical.

Step 4: Evaluate internal sales readiness

Do you have a lead generation engine (even basic outbound) or a CRM with clean data? If not, the CRO will need to build it from scratch.

Step 5: Interview for specific medtech domain knowledge

Ask about their experience with regulatory timelines, clinical champions, and hospital budget cycles — not just generic SaaS sales.

Step 6: Define scope and exit criteria

Set clear milestones (e.g., first 10 enterprise deals, repeatable sales process documented) and a timeline for transitioning to a full-time hire if needed.

Fractional CRO

Full-time VP of Sales (seed-stage)

Cost (monthly)

$5,000 - $18,000 + 0.5-2% equity

$15,000 - $25,000 salary + benefits + 2-5% equity

Commitment

2-8 days per week, flexible

5 days per week, full-time

Speed to impact

Immediate (existing playbooks)

3-6 months ramp-up

Risk

Low (easy to exit)

High (difficult to unwind)

Best for

Validating sales motion, building process

Scaling a proven, repeatable model

⚠️ Watch out

A fractional CRO cannot fix a broken product or nonexistent market need. If your medtech device or software hasn't demonstrated real traction with early adopters, no amount of revenue leadership will create demand. Invest in product-market fit first, then bring in the CRO.

The Medtech Reality: Why Seed Stage Is Different

Medtech is not SaaS. Your sales cycle can stretch 6-18 months, involve regulatory approvals (FDA 510(k), CE marking, or equivalent), and require buy-in from clinicians, hospital IT, legal, and procurement. A seed-stage medtech company with $500,000 in seed funding cannot afford to waste 6 months hiring a VP of Sales who may not understand these dynamics. A fractional CRO who has already navigated these waters brings a playbook — not a theoretical framework — for identifying clinical champions, managing regulatory timelines, and positioning your product against entrenched alternatives.

The key distinction is capital efficiency. Seed-stage medtech companies often have 12-18 months of runway. A full-time VP of Sales at $180,000 base salary plus benefits consumes roughly $15,000-$20,000 per month before any variable compensation. That's 10-15% of your monthly burn on a single hire who may not work out. A fractional CRO at $8,000-$12,000 per month for 4-6 days per week gives you experienced leadership without the fixed cost risk.

When a Fractional CRO Makes Sense (and When It Doesn't)

You should consider a fractional CRO if:

You have 5-10 paying customers and need to systematize the sales process. A fractional CRO can document your current wins, identify patterns, and build a repeatable motion.
Your sales cycle involves multiple stakeholders. Medtech buying decisions rarely involve one person. A fractional CRO with hospital system experience knows how to map decision-makers and manage long sales cycles.
You need to build a sales team but can't afford a full-time leader. A fractional CRO can hire and train your first 2-3 sales reps, then transition to an advisory role.
You're raising a Series A and need a credible revenue story. Investors want to see a repeatable sales process, not just founder-led sales. A fractional CRO adds credibility to your pitch.

You should not hire a fractional CRO if:

You haven't validated product-market fit. No sales leader can sell a product that doesn't solve a real problem. If you're still iterating on the product, focus on customer discovery, not sales process.
Your total addressable market is tiny. Medtech niches can be very small. If you're selling to 50 hospitals globally, a fractional CRO may be overkill — you might need founder-led sales and strategic partnerships instead.
You have less than 6 months of runway. A fractional CRO is an investment, not a magic wand. If you're running out of cash, prioritize fundraising or cost-cutting first.

How to Evaluate a Fractional CRO for Medtech

Not all fractional CROs are created equal. Here's what to look for:

Domain experience is non-negotiable. Medtech sales involve regulatory timelines, clinical trial data, and hospital procurement processes. A fractional CRO who has only sold SaaS will struggle. Ask for specific examples of how they've navigated FDA clearance timelines or hospital system RFPs.

References from similar-stage companies. A fractional CRO who has worked with pre-revenue companies is different from one who has only scaled $10M+ ARR businesses. Ask for references from seed-stage medtech founders who can speak to their ability to build from scratch.

A clear scope of work. Avoid vague "strategic advisory" arrangements. The best fractional CROs will define specific deliverables: sales process documentation, CRM setup, pipeline management, hiring plans, and monthly revenue forecasts. Expect a written agreement with measurable milestones.

Willingness to work in your tools. Most fractional CROs are proficient in Salesforce, HubSpot, or Pipedrive. They should also be comfortable with medtech-specific tools like Veeva or compliance platforms. Ask about their tech stack experience upfront.

flowchart TD A[Seed-stage medtech founder] --> B{Have 3-5 paying customers?} B -->|Yes| C{12+ months runway?} B -->|No| D[Invest in product-market fit first] C -->|Yes| E{Complex sales cycle?} C -->|No| F[Focus on fundraising or cost reduction] E -->|Yes| G[Fractional CRO likely beneficial] E -->|No| H[Consider founder-led sales or part-time sales rep] G --> I[Interview fractional CROs with medtech experience] I --> J[Define scope, milestones, and equity terms] J --> K[Evaluate after 6 months: transition to full-time or extend?]

The Economics: Cash vs. Equity

Fractional CRO compensation at seed stage typically involves a mix of cash and equity. Cash rates range from $5,000 to $18,000 per month, depending on the number of days per week (2-8 days) and the CRO's experience level. Equity grants are usually 0.5% to 2% of the company, vested over 2-4 years with a 1-year cliff. Some fractional CROs will accept a lower cash rate for higher equity, but this is less common — most need cash flow to cover their own overhead.

Compare this to a full-time VP of Sales: base salary of $150,000-$200,000 plus benefits (healthcare, 401k, etc.), plus equity of 2-5%. The full-time hire also requires office space, equipment, and potentially relocation costs. For a seed-stage company with limited cash, the fractional model preserves capital while providing experienced leadership.

Building the Sales Motion from Scratch

A fractional CRO's primary job at seed stage is to build a repeatable sales process. This includes:

CRM implementation. If you're using spreadsheets or Slack to track deals, the CRO will set up HubSpot or Salesforce with proper pipeline stages, lead scoring, and reporting.
Sales playbook creation. Documenting your current wins, identifying the ideal customer profile, and creating scripts for prospecting calls, demos, and follow-ups.
Hiring and training. The CRO will help you hire your first 1-3 sales reps, train them on your product and sales process, and manage their performance.
Pipeline generation. Working with marketing (if you have it) or building outbound sequences using tools like Outreach or Salesloft to generate leads.
Revenue forecasting. Building a repeatable forecasting process using tools like Clari or simple spreadsheets to predict monthly and quarterly revenue.

flowchart LR A[Founder-led sales] --> B{Deal volume increasing?} B -->|No| C[Continue founder-led sales] B -->|Yes| D[Fractional CRO] D --> E[CRM setup & pipeline management] D --> F[Sales playbook creation] D --> G[Hire & train first sales reps] D --> H[Revenue forecasting process] E --> I[Repeatable sales motion] F --> I G --> I H --> I I --> J[Transition to full-time VP of Sales]

The Transition Path: From Fractional to Full-Time

Most seed-stage medtech companies use a fractional CRO for 6-12 months before transitioning to a full-time hire. The fractional CRO can help define the role, interview candidates, and onboard the new VP of Sales. Some fractional CROs will stay on in an advisory capacity (2-4 days per month) after the transition.

The key is to set clear expectations upfront. Your agreement should include:

Duration. A 6-month initial term with a 30-day termination clause.
Milestones. Specific, measurable goals (e.g., "build a sales process for the top 3 customer segments" or "hire and train 2 sales reps").
Exit criteria. Conditions under which you'll transition to a full-time hire (e.g., "when monthly recurring revenue exceeds $50,000" or "when the sales process is documented and repeatable").

Common Pitfalls to Avoid

Expecting immediate results. A fractional CRO needs 30-60 days to understand your product, market, and existing pipeline. Don't expect a revenue surge in month one.

Over-relying on the CRO for everything. A fractional CRO is a leader, not a sales rep. They should be building systems, not making cold calls. If you need someone to dial for dollars, hire a sales development rep instead.

Ignoring the equity conversation. Seed-stage companies often undervalue equity. A fractional CRO who takes equity wants to see your company succeed. Treat them like a co-founder in terms of communication and transparency.

Hiring a generic SaaS CRO. Medtech is different. A CRO who has only sold B2B SaaS will struggle with regulatory timelines, clinical champions, and hospital procurement. Prioritize domain experience.

💡 Tip

When interviewing fractional CROs, ask this specific question: "Tell me about a time you sold into a hospital system with a 12-month sales cycle. What was your strategy for maintaining momentum with multiple stakeholders?" The answer will tell you more than any resume.

FAQ

What's the typical engagement length for a fractional CRO at seed stage? Most engagements last 6-12 months, with an option to extend or transition to a full-time role. Some companies keep a fractional CRO on an advisory basis (2-4 days per month) for longer periods.

How do I structure the equity component? Standard terms are 0.5-2% equity vested over 3-4 years with a 1-year cliff. The equity should be incentive stock options (ISOs) or non-qualified stock options (NSOs), depending on your corporate structure. Consult a startup attorney to draft the agreement.

Can a fractional CRO work remotely for a medtech company? Yes, most fractional CROs work remotely, especially if your local market has a thin talent pool for medtech sales leadership. They will need to travel for key customer meetings and team events, but the day-to-day work is typically remote.

What's the difference between a fractional CRO and a sales consultant? A fractional CRO is an embedded leader who takes ownership of the revenue function, manages a team, and is accountable for results. A sales consultant provides advice but doesn't execute. For seed-stage companies, a fractional CRO is usually more effective because they do the work, not just advise.

How do I know if the fractional CRO is performing? Set clear KPIs from day one: pipeline generated, deal velocity, conversion rates, and revenue booked. Review these monthly. If after 3 months you don't see measurable progress toward your milestones, it's time to reassess.

What tools should a fractional CRO be proficient in? Expect proficiency in a CRM (Salesforce, HubSpot), sales engagement platforms (Outreach, Salesloft), revenue intelligence (Gong, Clari), and basic analytics (Excel, Google Sheets). Medtech-specific tools like Veeva are a plus but not required.

Can I hire a fractional CRO if I'm pre-revenue? It's risky but possible. Pre-revenue companies should focus on product-market fit and customer discovery first. If you have a clear path to revenue (e.g., a signed pilot with a hospital system), a fractional CRO can help you build the sales process around that initial deal.

Sources

People also search for: fractional cro · hire a fractional cro · fractional cro near me · fractional cro cost

Download:

![Does a seed-stage medtech company need a fractional CRO in 2027?](/assets/cro-cover-4.jpg)

# Does a seed-stage medtech company need a fractional CRO in 2027?

```answer
Yes, if your medtech startup has achieved product-market validation and is ready to build a repeatable sales motion. A fractional CRO typically costs between $5,000 and $18,000 per month depending on scope (2-8 days per week), with an additional 0.5-2% equity grant for seed-stage companies. For a seed-stage medtech firm with limited cash and complex regulatory sales cycles, a fractional CRO is often the most capital-efficient way to access seasoned go-to-market leadership.
```

## Direct Answer

The short answer is: probably yes, but only if you have clear evidence of product-market fit and a handful of paying customers who aren't your co-founder's former colleagues. Medtech is a beast of its own — long sales cycles, regulatory hurdles, and multi-stakeholder buying groups that include clinicians, hospital administrators, and procurement teams. A fractional CRO brings the specific playbook for navigating these dynamics without the $200,000+ base salary and full benefits of a full-time hire. The real question isn't whether you *need* revenue leadership; it's whether you can afford to *not* have it while burning through seed capital on trial-and-error sales motions.

```steps
title: How to decide if a fractional CRO is right for your seed-stage medtech company
- Step 1: Validate real product-market fit | At least 3-5 non-referenceable customers paying for a solution that solves a specific clinical or operational pain point.
- Step 2: Assess your cash runway | Fractional CROs cost $5k-$18k/month; ensure you have at least 12-18 months of runway after this commitment.
- Step 3: Map your sales cycle complexity | If your deal involves FDA clearance, hospital system procurement, or multi-stakeholder approvals, a fractional CRO with medtech experience is critical.
- Step 4: Evaluate internal sales readiness | Do you have a lead generation engine (even basic outbound) or a CRM with clean data? If not, the CRO will need to build it from scratch.
- Step 5: Interview for specific medtech domain knowledge | Ask about their experience with regulatory timelines, clinical champions, and hospital budget cycles — not just generic SaaS sales.
- Step 6: Define scope and exit criteria | Set clear milestones (e.g., first 10 enterprise deals, repeatable sales process documented) and a timeline for transitioning to a full-time hire if needed.
```

```compare
a: Fractional CRO
b: Full-time VP of Sales (seed-stage)
- Cost (monthly) | $5,000 - $18,000 + 0.5-2% equity | $15,000 - $25,000 salary + benefits + 2-5% equity
- Commitment | 2-8 days per week, flexible | 5 days per week, full-time
- Speed to impact | Immediate (existing playbooks) | 3-6 months ramp-up
- Risk | Low (easy to exit) | High (difficult to unwind)
- Best for | Validating sales motion, building process | Scaling a proven, repeatable model
```

```callout
type: warning
A fractional CRO cannot fix a broken product or nonexistent market need. If your medtech device or software hasn't demonstrated real traction with early adopters, no amount of revenue leadership will create demand. Invest in product-market fit first, then bring in the CRO.
```

## The Medtech Reality: Why Seed Stage Is Different

Medtech is not SaaS. Your sales cycle can stretch 6-18 months, involve regulatory approvals (FDA 510(k), CE marking, or equivalent), and require buy-in from clinicians, hospital IT, legal, and procurement. A seed-stage medtech company with $500,000 in seed funding cannot afford to waste 6 months hiring a VP of Sales who may not understand these dynamics. A fractional CRO who has already navigated these waters brings a **playbook** — not a theoretical framework — for identifying clinical champions, managing regulatory timelines, and positioning your product against entrenched alternatives.

The key distinction is **capital efficiency**. Seed-stage medtech companies often have 12-18 months of runway. A full-time VP of Sales at $180,000 base salary plus benefits consumes roughly $15,000-$20,000 per month before any variable compensation. That's 10-15% of your monthly burn on a single hire who may not work out. A fractional CRO at $8,000-$12,000 per month for 4-6 days per week gives you experienced leadership without the fixed cost risk.

## When a Fractional CRO Makes Sense (and When It Doesn't)

You should consider a fractional CRO if:

- **You have 5-10 paying customers** and need to systematize the sales process. A fractional CRO can document your current wins, identify patterns, and build a repeatable motion.
- **Your sales cycle involves multiple stakeholders.** Medtech buying decisions rarely involve one person. A fractional CRO with hospital system experience knows how to map decision-makers and manage long sales cycles.
- **You need to build a sales team but can't afford a full-time leader.** A fractional CRO can hire and train your first 2-3 sales reps, then transition to an advisory role.
- **You're raising a Series A and need a credible revenue story.** Investors want to see a repeatable sales process, not just founder-led sales. A fractional CRO adds credibility to your pitch.

You should **not** hire a fractional CRO if:

- **You haven't validated product-market fit.** No sales leader can sell a product that doesn't solve a real problem. If you're still iterating on the product, focus on customer discovery, not sales process.
- **Your total addressable market is tiny.** Medtech niches can be very small. If you're selling to 50 hospitals globally, a fractional CRO may be overkill — you might need founder-led sales and strategic partnerships instead.
- **You have less than 6 months of runway.** A fractional CRO is an investment, not a magic wand. If you're running out of cash, prioritize fundraising or cost-cutting first.


[![CRO Syndicate — Need a fractional Chief Revenue Officer? CRO Syndicate connects you with vetted fractional and interim revenue leaders. Kory White, Fractional CRO · 25 yrs · $0 to $200M scaled.](https://wsrv.nl/?url=files.catbox.moe/usgv65.png&w=1280&output=webp)](https://calendly.com/korywhiterevops)

**Reach Kory White, Fractional CRO:** [📅 Book a Quick Call](https://calendly.com/korywhiterevops) · [💼 Kory on LinkedIn](https://www.linkedin.com/in/korywhite) · [🏢 CRO Syndicate](https://crosyndicate.com/)

## How to Evaluate a Fractional CRO for Medtech

Not all fractional CROs are created equal. Here's what to look for:

**Domain experience is non-negotiable.** Medtech sales involve regulatory timelines, clinical trial data, and hospital procurement processes. A fractional CRO who has only sold SaaS will struggle. Ask for specific examples of how they've navigated FDA clearance timelines or hospital system RFPs.

**References from similar-stage companies.** A fractional CRO who has worked with pre-revenue companies is different from one who has only scaled $10M+ ARR businesses. Ask for references from seed-stage medtech founders who can speak to their ability to build from scratch.

**A clear scope of work.** Avoid vague "strategic advisory" arrangements. The best fractional CROs will define specific deliverables: sales process documentation, CRM setup, pipeline management, hiring plans, and monthly revenue forecasts. Expect a written agreement with measurable milestones.

**Willingness to work in your tools.** Most fractional CROs are proficient in Salesforce, HubSpot, or Pipedrive. They should also be comfortable with medtech-specific tools like Veeva or compliance platforms. Ask about their tech stack experience upfront.

```mermaid
flowchart TD
    A[Seed-stage medtech founder] --> B{Have 3-5 paying customers?}
    B -->|Yes| C{12+ months runway?}
    B -->|No| D[Invest in product-market fit first]
    C -->|Yes| E{Complex sales cycle?}
    C -->|No| F[Focus on fundraising or cost reduction]
    E -->|Yes| G[Fractional CRO likely beneficial]
    E -->|No| H[Consider founder-led sales or part-time sales rep]
    G --> I[Interview fractional CROs with medtech experience]
    I --> J[Define scope, milestones, and equity terms]
    J --> K[Evaluate after 6 months: transition to full-time or extend?]
```

## The Economics: Cash vs. Equity

Fractional CRO compensation at seed stage typically involves a mix of cash and equity. Cash rates range from **$5,000 to $18,000 per month**, depending on the number of days per week (2-8 days) and the CRO's experience level. Equity grants are usually **0.5% to 2%** of the company, vested over 2-4 years with a 1-year cliff. Some fractional CROs will accept a lower cash rate for higher equity, but this is less common — most need cash flow to cover their own overhead.

Compare this to a full-time VP of Sales: base salary of **$150,000-$200,000** plus benefits (healthcare, 401k, etc.), plus equity of **2-5%**. The full-time hire also requires office space, equipment, and potentially relocation costs. For a seed-stage company with limited cash, the fractional model preserves capital while providing experienced leadership.

## Building the Sales Motion from Scratch

A fractional CRO's primary job at seed stage is to build a repeatable sales process. This includes:

- **CRM implementation.** If you're using spreadsheets or Slack to track deals, the CRO will set up HubSpot or Salesforce with proper pipeline stages, lead scoring, and reporting.
- **Sales playbook creation.** Documenting your current wins, identifying the ideal customer profile, and creating scripts for prospecting calls, demos, and follow-ups.
- **Hiring and training.** The CRO will help you hire your first 1-3 sales reps, train them on your product and sales process, and manage their performance.
- **Pipeline generation.** Working with marketing (if you have it) or building outbound sequences using tools like Outreach or Salesloft to generate leads.
- **Revenue forecasting.** Building a repeatable forecasting process using tools like Clari or simple spreadsheets to predict monthly and quarterly revenue.

```mermaid
flowchart LR
    A[Founder-led sales] --> B{Deal volume increasing?}
    B -->|No| C[Continue founder-led sales]
    B -->|Yes| D[Fractional CRO]
    D --> E[CRM setup & pipeline management]
    D --> F[Sales playbook creation]
    D --> G[Hire & train first sales reps]
    D --> H[Revenue forecasting process]
    E --> I[Repeatable sales motion]
    F --> I
    G --> I
    H --> I
    I --> J[Transition to full-time VP of Sales]
```

## The Transition Path: From Fractional to Full-Time

Most seed-stage medtech companies use a fractional CRO for **6-12 months** before transitioning to a full-time hire. The fractional CRO can help define the role, interview candidates, and onboard the new VP of Sales. Some fractional CROs will stay on in an advisory capacity (2-4 days per month) after the transition.

The key is to set clear expectations upfront. Your agreement should include:

- **Duration.** A 6-month initial term with a 30-day termination clause.
- **Milestones.** Specific, measurable goals (e.g., "build a sales process for the top 3 customer segments" or "hire and train 2 sales reps").
- **Exit criteria.** Conditions under which you'll transition to a full-time hire (e.g., "when monthly recurring revenue exceeds $50,000" or "when the sales process is documented and repeatable").

## Common Pitfalls to Avoid

**Expecting immediate results.** A fractional CRO needs 30-60 days to understand your product, market, and existing pipeline. Don't expect a revenue surge in month one.

**Over-relying on the CRO for everything.** A fractional CRO is a leader, not a sales rep. They should be building systems, not making cold calls. If you need someone to dial for dollars, hire a sales development rep instead.

**Ignoring the equity conversation.** Seed-stage companies often undervalue equity. A fractional CRO who takes equity wants to see your company succeed. Treat them like a co-founder in terms of communication and transparency.

**Hiring a generic SaaS CRO.** Medtech is different. A CRO who has only sold B2B SaaS will struggle with regulatory timelines, clinical champions, and hospital procurement. Prioritize domain experience.

```callout
type: tip
When interviewing fractional CROs, ask this specific question: "Tell me about a time you sold into a hospital system with a 12-month sales cycle. What was your strategy for maintaining momentum with multiple stakeholders?" The answer will tell you more than any resume.
```

## FAQ

**What's the typical engagement length for a fractional CRO at seed stage?**
Most engagements last 6-12 months, with an option to extend or transition to a full-time role. Some companies keep a fractional CRO on an advisory basis (2-4 days per month) for longer periods.

**How do I structure the equity component?**
Standard terms are 0.5-2% equity vested over 3-4 years with a 1-year cliff. The equity should be incentive stock options (ISOs) or non-qualified stock options (NSOs), depending on your corporate structure. Consult a startup attorney to draft the agreement.

**Can a fractional CRO work remotely for a medtech company?**
Yes, most fractional CROs work remotely, especially if your local market has a thin talent pool for medtech sales leadership. They will need to travel for key customer meetings and team events, but the day-to-day work is typically remote.

**What's the difference between a fractional CRO and a sales consultant?**
A fractional CRO is an embedded leader who takes ownership of the revenue function, manages a team, and is accountable for results. A sales consultant provides advice but doesn't execute. For seed-stage companies, a fractional CRO is usually more effective because they do the work, not just advise.

**How do I know if the fractional CRO is performing?**
Set clear KPIs from day one: pipeline generated, deal velocity, conversion rates, and revenue booked. Review these monthly. If after 3 months you don't see measurable progress toward your milestones, it's time to reassess.

**What tools should a fractional CRO be proficient in?**
Expect proficiency in a CRM (Salesforce, HubSpot), sales engagement platforms (Outreach, Salesloft), revenue intelligence (Gong, Clari), and basic analytics (Excel, Google Sheets). Medtech-specific tools like Veeva are a plus but not required.

**Can I hire a fractional CRO if I'm pre-revenue?**
It's risky but possible. Pre-revenue companies should focus on product-market fit and customer discovery first. If you have a clear path to revenue (e.g., a signed pilot with a hospital system), a fractional CRO can help you build the sales process around that initial deal.

## Sources

- [Pavilion - Community for revenue leaders](https://joinpavilion.com)
- [RevOps Co-op - Revenue operations community](https://revops.coop)
- [Harvard Business Review - Sales leadership articles](https://hbr.org)
- [First Round Review - Startup sales advice](https://review.firstround.com)
- [SaaStr - SaaS and revenue growth insights](https://saastr.com)
- [LinkedIn - Professional network for CRO candidates](https://linkedin.com)

**People also search for:** fractional cro · hire a fractional cro · fractional cro near me · fractional cro cost

Was this helpful?

⌬ Apply this in PULSE

Gross Profit CalculatorModel margin per deal, per rep, per territory

Deep dive · related in the library